Clinical Trial

A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-05.
Trial Details
NCT Number NCT07292779
Lead Sponsor Samyang Biopharmaceuticals Corporation
Conditions Nasolabial Folds, Wrinkles
Enrollment 30 participants
Start Date 2025-11-24
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-05